Chloroquine as a promising adjuvant therapy for type 1 Diabetes Mellitus

Chloroquine (CQ) and hydroxychloroquine, are promising anti-inflammatory drugs for the treatment of Diabetes mellitus (DM) to prevent associated complications. Therefore, this study evaluated the anti-inflammatory effects of CQ-free and CQ-incorporated polylactic acid nanoparticles (NPs) in the peri...

Descripción completa

Detalles Bibliográficos
Autores principales: de Almeida Júnior, Renato Ferreira, de Souza, Karla Simone Costa, Galdino, Ony Araujo, da Silva Junior, Arnóbio Antônio, Arrais, Ricardo Fernando, Machado, Paula Renata Lima, Farias, Kleber Juvenal Silva, de Rezende, Adriana Augusto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374610/
https://www.ncbi.nlm.nih.gov/pubmed/32694530
http://dx.doi.org/10.1038/s41598-020-69001-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374610/
https://www.ncbi.nlm.nih.gov/pubmed/32694530
http://dx.doi.org/10.1038/s41598-020-69001-2

Ejemplares similares